Your session is about to expire
← Back to Search
Multimodality Treatment for Endometrial Cancer
Study Summary
This trial is studying a combination of chemotherapy and radiation therapy as a potential treatment for endometrial cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are being considered for a combination of treatments that includes surgery, chemotherapy with carbo/Taxol, and radiation therapy.You cannot receive treatment that combines different therapies.
- Group 1: Quality of life evaluation
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the Quality of Life questionnaire been given official endorsement by the US Food and Drug Administration?
"Our team has gauged the Quality of Life questionnaire's safety as a 2, in accordance with its phase 2 status. This is because there are some data points that demonstrate safety but minimal to no evidence demonstrating efficacy."
Is there an age limit for participating in this research endeavor?
"Adults aged 18 to 90 are eligible for this investigation, while separate clinical trials exist for minors (18 and under) and seniors (65+). Specifically, there are eighteen studies available to those younger than 18 years old and two hundred seventy-six open slots in research accessible by the elderly."
Who would be a qualified candidate for this medical experiment?
"This clinical trial is seeking 60 individuals to participate in the study, between 18 and 90 years of age, who have been diagnosed with endometrial cancer."
How many participants are being recruited for this trial?
"Affirmative. The clinical trial, which was first published on February 27th 2020 is still recruiting participants as per the latest information provided by clinicaltrials.gov. A total of 60 patients must be enrolled at a single site for this study to proceed with its objectives."
Are there still vacancies in this experiment?
"According to the clinicaltrials.gov portal, this research is currently enrolling participants with a study start date of February 27th 2020 and an update on February 22nd 2022."
Share this study with friends
Copy Link
Messenger